NDC 51862-100-01 - Errin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51862-100
- Requested NDC
- 51862-100-01
- Package NDCs from labels
- 51862-100-01, 51862-100-06
- Manufacturer
- Mayne Pharma Inc. | Teva Women's Health, Inc.
- Effective date
- 2018-10-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Errin ® (norethindrone tablets USP 0.35 mg) | Mayne Pharma Inc. | Teva Women's Health, Inc. | 2018-10-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51862-100-01 | EA - Each | 51862-100 | 8bf50645-c5e8-4421-959e-00ea2c9f56ea | 1 | 2017-03-06 |
| 51862-100-06 | EA - Each | 51862-100 | 744b31fc-17a0-46ef-941d-73ec3005d724 | 1 | 2017-03-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | Teva Pharmaceuticals USA, Inc. | 140c50d6-c931-423a-9aa0-526eae7ab93c | 2021-12-01 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
| Incassia | NORETHINDRONE | Aurobindo Pharma Limited | 0b87cef0-610c-469d-92ba-4007f4bc3878 | 2021-09-14 | Warnings, Adverse reactions | T18F433X4S |
| Norethindrone | NORETHINDRONE | Proficient Rx LP | fb84b86e-5f1f-4c17-8b69-ff695c5faf55 | 2019-11-01 | Warnings, Adverse reactions | T18F433X4S |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
| 05c452d3-dfac-4036-8c2d-536a03ed99a0 | b98c5463-7f38-440d-928c-c0fa722b28ae | 2018-10-17 | Warnings, Adverse reactions | 05c452d3-dfac-4036-8c2d-536a03ed99a0 b98c5463-7f38-440d-928c-c0fa722b28ae |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.